Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

With brand-name GLP-1s for obesity treatment on and off the shortage list, prescribing can get complicated. Five providers ...

If you have trouble affording prescription drugs, some independent pharmacists say that so-called pharmacy middlemen are ...